Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine
- 28 May 2013
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 98 (8) , e85-e86
- https://doi.org/10.3324/haematol.2012.079921
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter StudyJournal of Clinical Oncology, 2012
- Long‐term follow‐up of patients with HIV‐related diffuse large B‐cell lymphomas treated in a phase II study with rituximab and CHOPBritish Journal of Haematology, 2012
- Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort studyAIDS, 2009
- Human immunodeficiency virus-related non-Hodgkin's lymphomaHaematologica, 2008
- Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003Annals of Internal Medicine, 2008
- Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphomaHaematologica, 2007
- Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus‐associated Hodgkin's diseaseBritish Journal of Haematology, 2004
- Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's diseaseAIDS, 2002
- Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infectionBlood, 2002
- Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity.1998